AJMC June 20, 2021
A poster presented at the Academy of Managed Care Pharmacy 2021 meeting, April 12-16, 2021, examined how payers in the United States are using oncology clinical pathways (OCPs) to understand what drives their development and uptake and to delineate what barriers prevent further OCP adoption.
The use of OCPs, which first appeared about a decade ago, has grown in recent years. In 2016, they were used by 58% of oncology practices, which was 42% more than in 2014.
This research examined how OCPs initiated by payers affected access to oncology treatments, as payers seek ways to manage high-cost oncology care while ensuring value-based care. The research was conducted by Xcenda, part of AmerisourceBergen.
An electronic payer survey containing multiple-choice, open-ended,...